Literature DB >> 25328957

Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders.

Claudia Sannibale1, Maree Teesson, Mark Creamer, Thiagarajan Sitharthan, Richard A Bryant, Kylie Sutherland, Kirsten Taylor, Delphine Bostock-Matusko, Alicia Visser, Marie Peek-O'Leary.   

Abstract

Aims This study aimed to test the efficacy of integrated cognitive behaviour therapy (CBT) for coexisting post traumatic stress disorder (PTSD) and alcohol use disorders (AUD). Setting Clinics across Sydney, Australia.Design Randomized controlled trial of 12 once-weekly individual sessions of either integrated CBT for PTSD and AUD(integrated therapy, IT; n = 33) or CBT for AUD plus supportive counselling (alcohol-support, AS; n = 29). Blind assessments were conducted at baseline and post-treatment and at 5 [standard deviation (SD) = 2.25] and 9.16(SD = 3.45) months post-treatment. Participants Sixty-two adults with concurrent PTSD and AUD. Measurements Outcomes included changes in alcohol consumption (time-line follow-back), PTSD severity [clinician-administered PTSD scale (CAPS)], alcohol dependence and problems, and depression and anxiety. Findings Reductions in PTSD severity were evident in both groups. IT participants who had received one or more sessions of exposure therapy exhibited a twofold greater rate of clinically significant change in CAPS severity at follow-up than AS participants [IT60%, AS 39%, odds ratio (OR): 2.31, 95% confidence interval (CI): 1.06, 5.01]. AS participants exhibited larger reductions than IT participants in alcohol consumption, dependence and problems within the context of greater treatment from other services during follow-up. Results lend support to a mutually maintaining effect between AUD and PTSD. Conclusions Individuals with severe and complex presentations of coexisting post-traumatic stress disorder(PTSD) and alcohol use disorders (AUD) can derive substantial benefit from cognitive behaviour therapy targeting AUD, with greater benefits associated with exposure for PTSD. Among individuals with dual disorders, these therapies can generate significant, well-maintained treatment effects on PTSD, AUD and psychopathology.

Entities:  

Mesh:

Year:  2013        PMID: 25328957     DOI: 10.1111/add.12167

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  32 in total

1.  Pre-treatment predictors of dropout from prolonged exposure therapy in patients with chronic posttraumatic stress disorder and comorbid substance use disorders.

Authors:  Emily L Belleau; Eu Gene Chin; Sonya G Wanklyn; Laura Zambrano-Vazquez; Julie A Schumacher; Scott F Coffey
Journal:  Behav Res Ther       Date:  2017-01-25

2.  Treatment of co-occurring PTSD-AUD: effects of exposure-based and non-trauma focused psychotherapy on alcohol and trauma cue-reactivity.

Authors:  Elizabeth Nosen; Andrew K Littlefield; Julie A Schumacher; Paul R Stasiewicz; Scott F Coffey
Journal:  Behav Res Ther       Date:  2014-07-22

Review 3.  At the crossroads: the intersection of substance use disorders, anxiety disorders, and posttraumatic stress disorder.

Authors:  Lesia M Ruglass; Teresa Lopez-Castro; Soumia Cheref; Santiago Papini; Denise A Hien
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

4.  [Evidence-based psychotherapy of addictive disorders].

Authors:  I Block; S Loeber
Journal:  Nervenarzt       Date:  2018-03       Impact factor: 1.214

5.  Combining seeking safety with sertraline for PTSD and alcohol use disorders: A randomized controlled trial.

Authors:  Denise A Hien; Frances Rudnick Levin; Lesia M Ruglass; Teresa López-Castro; Santiago Papini; Mei-Chen Hu; Lisa Renee Cohen; Abigail Herron
Journal:  J Consult Clin Psychol       Date:  2015-01-26

6.  Concurrent treatment of posttraumatic stress disorder and alcohol dependence: Predictors and moderators of outcome.

Authors:  Laurie J Zandberg; David Rosenfield; Carmen P McLean; Mark B Powers; Anu Asnaani; Edna B Foa
Journal:  J Consult Clin Psychol       Date:  2015-10-12

7.  Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial.

Authors:  Lesia M Ruglass; Teresa Lopez-Castro; Santiago Papini; Therese Killeen; Sudie E Back; Denise A Hien
Journal:  Psychother Psychosom       Date:  2017-05-11       Impact factor: 17.659

Review 8.  Psychiatric comorbidity in alcohol use disorders: results from the German S3 guidelines.

Authors:  U W Preuss; E Gouzoulis-Mayfrank; U Havemann-Reinecke; I Schäfer; M Beutel; E Hoch; K F Mann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-24       Impact factor: 5.270

9.  [Mental comorbidities of alcohol-related disorders].

Authors:  U W Preuss; E Gouzoulis-Mayfrank; U Havemann-Reinecke; I Schäfer; M Beutel; K F Mann; E Hoch
Journal:  Nervenarzt       Date:  2016-01       Impact factor: 1.214

10.  Predictors of dropout in concurrent treatment of posttraumatic stress disorder and alcohol dependence: Rate of improvement matters.

Authors:  Laurie J Zandberg; David Rosenfield; Elizabeth Alpert; Carmen P McLean; Edna B Foa
Journal:  Behav Res Ther       Date:  2016-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.